On October 22, 2015, David Lowe resigned as a member of the Board of Directors of Amarantus Bioscience Holdings, Inc, effective immediately, for personal reasons and after terminating the consulting agreement dated November 1, 2014 by and between the Company and NeuroAssets Sarl. Dr. Lowe is President and CEO of NeuroAssets Sarl.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | -.--% | -.--% | -80.00% |
1st Jan change | Capi. | |
---|---|---|
-80.00% | 63.04K | |
+43.36% | 54.63B | |
-5.31% | 39.92B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B | |
-11.83% | 10.74B |
- Stock Market
- Equities
- AMBS Stock
- News Amarantus BioScience Holdings, Inc.
- Amarantus Bioscience Holdings, Inc Announces Resignation of David Lowe as a Member of the Board of Directors